NCT05263492 2025-10-02
Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer
Virginia Commonwealth University
Phase 2 Terminated
Clinical Trials
5 trialsNCT07077798 2025-07-22
Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection
Tongji Hospital
Phase NA Not yet recruiting
NCT06420440 2025-05-01
Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model
Tongji Hospital
Phase 2 Recruiting
NCT06253364 2024-03-13
VETC is an Effective Marker for Postoperative Adjuvant Immunotherapy
Tongji Hospital
Completed
NCT05910970 2024-01-23
PREVENT-2
Guangxi Medical University
Phase 3 Unknown